311 related articles for article (PubMed ID: 22881440)
1. Spray drying from organic solvents to prepare nanoporous/nanoparticulate microparticles of protein: excipient composites designed for oral inhalation.
Ní Ógáin O; Tajber L; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Sep; 64(9):1275-90. PubMed ID: 22881440
[TBL] [Abstract][Full Text] [Related]
2. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
[TBL] [Abstract][Full Text] [Related]
3. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
[TBL] [Abstract][Full Text] [Related]
4. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
Amaro MI; Tajber L; Corrigan OI; Healy AM
Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
[TBL] [Abstract][Full Text] [Related]
5. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation.
Amaro MI; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Dec; 421(1):99-109. PubMed ID: 21963473
[TBL] [Abstract][Full Text] [Related]
6. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
Gad S; Tajber L; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Sep; 64(9):1264-74. PubMed ID: 22881439
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide.
Healy AM; McDonald BF; Tajber L; Corrigan OI
Eur J Pharm Biopharm; 2008 Aug; 69(3):1182-6. PubMed ID: 18595674
[TBL] [Abstract][Full Text] [Related]
9. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
[TBL] [Abstract][Full Text] [Related]
10. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
12. Impact of process variables on the micromeritic and physicochemical properties of spray-dried microparticles--Part II. Physicochemical characterisation of spray-dried materials.
Paluch KJ; Tajber L; Amaro MI; Corrigan OI; Healy AM
J Pharm Pharmacol; 2012 Nov; 64(11):1583-91. PubMed ID: 23058045
[TBL] [Abstract][Full Text] [Related]
13. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of some water-miscible organic solvents for spray-drying enzymes and carbohydrates.
Sass A; Lee G
Drug Dev Ind Pharm; 2014 Jun; 40(6):749-57. PubMed ID: 23596974
[TBL] [Abstract][Full Text] [Related]
15. Influence of protein on mannitol polymorphic form produced during co-spray drying.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
[TBL] [Abstract][Full Text] [Related]
16. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
[TBL] [Abstract][Full Text] [Related]
17. The influence of formulation components on the aerosolisation properties of spray-dried powders.
Rabbani NR; Seville PC
J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
[TBL] [Abstract][Full Text] [Related]
18. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
Hugo M; Kunath K; Dressman J
Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
[TBL] [Abstract][Full Text] [Related]
19. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
[TBL] [Abstract][Full Text] [Related]
20. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
